Matthew Resnick, M.D., M.P.H., is associate professor of urology and health policy at Vanderbilt University Medical Center. His research focuses on the implications of Medicare ACO enrollment on appropriateness of cancer screening to determine the net effect of shared savings and quality measurement on the delivery of recommended and discretionary health care services. Resnick is interested in comparative effectiveness research and prostate cancer survivorship.
